Paroxetine Hydrochloride
Product Images NDC 69986-011

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 69986-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sinotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12.5mg-blister (12.5mg Blister)

Paroxetine Extended-Release Tablets, USP 12.5 mg packaging label from Sinotherapeutics Inc. The label shows the product name prominently along with the strength of 12.5 mg. It includes information about the dosing form as unit-dose tablets, package quantity (30 tablets), storage instructions, manufacturing details, and a barcode. The label is marked for hospital use only and prescription dispensing instructions are noted.*

FDA Label Image

12.5mg-bottle (12.5mg Hdpe)

Paroxetine hydrochloride extended-release tablets, USP 12.5 mg, manufactured by Sinotherapeutics Inc. The label indicates 30 tablets per package and includes dosage form as film-coated, extended-release tablets. The label also contains storage instructions, manufacturer and distributor addresses in China, and a barcode.*

FDA Label Image

25mg-blister (25mg Blister)

Packaging label for Paroxetine Extended-Release Tablets, USP 25 mg by Sinotherapeutics Inc. The label includes the product name and strength prominently, mentions the medication is for hospital use only, and contains 30 unit-dose tablets (3x10). Manufacturer addresses in Shanghai and Jiangsu, China, are listed, along with storage instructions and a barcode.*

FDA Label Image

25mg-bottle (25mg Hdpe)

The packaging label for Paroxetine Extended-Release Tablets, USP, 25 mg by Sinotherapeutics Inc. The label states it contains 30 extended-release film-coated tablets. It includes storage instructions, dispensing guidance, and manufacturer details from Sinotherapeutics Inc. in Shanghai and Haimen Pharma Inc. in Jiangsu, China.*

FDA Label Image

37.5mg Hdpe

Paroxetine Extended-Release Tablets, USP 37.5 mg label from Sinotherapeutics Inc. The label includes storage instructions, dosage warnings, manufacturer details, and specifies the package contains 30 film-coated extended-release tablets with paroxetine hydrochloride equivalent to 37.5 mg paroxetine.*

FDA Label Image

Figure1 (Figure 1)

A forest plot graph showing fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for various interacting drugs relative to reference. Drugs listed include Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The horizontal axis represents change relative to reference on a logarithmic scale ranging from 0.1 to 10.*

FDA Label Image

Figure2 (Figure 2)

A scatter plot chart showing the pharmacokinetic interaction of various drugs (Cimetidine, Phenobarbital, Phenytoin, Digoxin, Diazepam) with paroxetine hydrochloride, measuring fold change and 90% confidence intervals for Cmax and AUC relative to reference values.*

FDA Label Image

Figure3 (Figure 3)

A forest plot chart depicting pharmacokinetic (PK) changes in paroxetine hydrochloride involving Cmax, AUC, and Cmin metrics across populations with varying renal and hepatic impairments, age groups dosed once daily, and gender (males). The chart shows fold changes and 90% confidence intervals relative to a reference value on a logarithmic scale from 0.5 to 50.*

FDA Label Image

Structure (Structure)

Chemical structure of paroxetine hydrochloride showing its molecular composition including aromatic rings and specific functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.